Economic catalyst

Tech leader Christine Heckart joins Contentful board of directors

Retrieved on: 
Tuesday, February 9, 2021
Eileen Heckart, Scalyr, Economic catalyst, Actors, Theatre, Economy

SAN FRANCISCO and BERLIN, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Contentful , the leading content platform for digital-first businesses, today announced that Christine Heckart, Chief Executive Officer of Scalyr , has joined its board of directors.

Key Points: 
  • SAN FRANCISCO and BERLIN, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Contentful , the leading content platform for digital-first businesses, today announced that Christine Heckart, Chief Executive Officer of Scalyr , has joined its board of directors.
  • "I am delighted to join the board of directors at this exciting time in Contentful's trajectory," said Heckart.
  • As an early member of the All Raise Board Xcelerate program, it's clear to me that Contentful believes this too."
  • Heckart joins Contentful board members from Balderton Capital, Benchmark, General Catalyst and Sapphire Ventures.

Catalyst Biosciences to Present at Stifel 2020 Virtual Healthcare Conference

Retrieved on: 
Tuesday, November 3, 2020
Articles, Communication, Forward-looking statement, Statement, Economic catalyst

Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in rare hematologic and complement-mediated disorders.

Key Points: 
  • Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in rare hematologic and complement-mediated disorders.
  • Forward-looking statements include statements about the product candidates generated by Catalysts protease engineering platform having improved functionality and potency.
  • Actual results or events could differ materially from the plans, intentions, expectations and projections disclosed in the forward-looking statements.
  • The Company does not assume any obligation to update any forward-looking statements, except as required by law.

Catalyst Regeneration Market 2020-2024: Post-Pandemic Industry Planning Structure | Technavio

Retrieved on: 
Thursday, October 29, 2020
Chemicals, Plastics, Manufacturing, Albemarle Corporation, Articles, Physical sciences, Chemistry, Economic catalyst, Catalyst, Lithium, Regeneration, Urban renewal

The catalyst regeneration market is expected to grow by USD 1.18 billion during 2020-2024, according to Technavio.

Key Points: 
  • The catalyst regeneration market is expected to grow by USD 1.18 billion during 2020-2024, according to Technavio.
  • View the full release here: https://www.businesswire.com/news/home/20201029005192/en/
    Technavio has announced its latest market research report titled Global Catalyst Regeneration Market 2020-2024 (Graphic: Business Wire)
    Enterprises will go through Response, Recovery and Renew phases.
  • Click here
    Key Considerations for Market Forecast:
    Major Three Catalyst Regeneration Market Participants:
    Albemarle Corp. operates its business under various segments such as Lithium, Bromine specialties, and catalysts.
  • Get report snapshot here to get detailed market share analysis of market participants during COVID-19 lockdown: https://www.technvaio.com/report/catalyst-regeneration-market-industry-a...
    Catalyst regeneration market is segmented as below:

TANAKA Receives 2020 Technology Award from Catalyst Manufacturers Association, Japan

Retrieved on: 
Thursday, October 29, 2020
Tanaka Kikinzoku, Catalysis, Catalyst, Economic catalyst

(Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which operates the TANAKA Precious Metals manufacturing business, has received the 2020 Technology Award from the Catalyst Manufacturers Association, Japan, (CMAJ).

Key Points: 
  • (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which operates the TANAKA Precious Metals manufacturing business, has received the 2020 Technology Award from the Catalyst Manufacturers Association, Japan, (CMAJ).
  • Hitoshi Kubo, from TANAKA, and Yasunori Iwai, from QST, received the award and gave an acceptance speech at the 2020 CMAJ award ceremony, held online on October 14.
  • The hydrophobic precious metal catalyst for which the Technology Award was received was developed through a collaboration between TANAKA and QST.
  • [2020 Technology Award from Catalyst Manufacturers Association, Japan]
    Catalyst Manufacturers Association, Japan, was founded to promote the sound development of Japan's catalyst industry, including companies manufacturing catalysts, producing catalyst-related materials, and dealing with catalyst products.

McNulty Prize Catalyst Fund Awarded to Emerging Organizations Challenging Entrenched Inequities

Retrieved on: 
Wednesday, October 14, 2020
NeXT, Catalyst, Catalysis, Economic catalyst

New York, NY, Oct. 14, 2020 (GLOBE NEWSWIRE) -- The McNulty Foundation and the Aspen Institute announced the 2020 recipients of the McNulty Prize Catalyst Fund.

Key Points: 
  • New York, NY, Oct. 14, 2020 (GLOBE NEWSWIRE) -- The McNulty Foundation and the Aspen Institute announced the 2020 recipients of the McNulty Prize Catalyst Fund.
  • We started the Catalyst Fund to boost proven leaders and support their organizations to move to the next phase of their impact.
  • Congratulations to the 2020 McNulty Prize Catalyst Fund recipients:
    Race and equity leader Michelle Molitor catalyzes individuals and teams as change agents who can lead collective anti-racist actions in their organizations.
  • About the Catalyst Fund & the John P. McNulty Prize
    The McNulty Prize Catalyst Fund recognizes ventures with significant momentum at critical junctures on their path to creating meaningful change.

Catalyst Biosciences Present at the Raymond James Human Health Innovation Conference

Retrieved on: 
Friday, June 12, 2020
Cisco Catalyst, Catalyst, Economic catalyst

SOUTH SAN FRANCISCO, Calif., June 12, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced thatNassim Usman, Ph.D., president and chief executive officer of Catalyst Biosciences, will present a corporate overview at the Raymond James Human Health Innovation Conference at 3:00 pm ET on Thursday, June 18, 2020.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., June 12, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced thatNassim Usman, Ph.D., president and chief executive officer of Catalyst Biosciences, will present a corporate overview at the Raymond James Human Health Innovation Conference at 3:00 pm ET on Thursday, June 18, 2020.
  • Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet needs in rare hematologic and systemic complement-mediated disorders.
  • One of our key competitive advantages is that the product candidates generated by our protease engineering platform have improved functionality and potency.
  • The Company does not assume any obligation to update any forward-looking statements, except as required by law.

Mark Templeton Appointed to Health Catalyst Board of Directors

Retrieved on: 
Tuesday, May 12, 2020
Templeton, Catalyst, Catalysis, Economic catalyst

SALT LAKE CITY, May 12, 2020 (GLOBE NEWSWIRE) -- The board of directors (the Board) of Health Catalyst, Inc. ("Health Catalyst, Nasdaq: HCAT ), a leading provider of data and analytics technology and services to healthcare organizations, named Mark Templeton to its Board and its nominating and corporate governance committee, effective June 15, 2020.

Key Points: 
  • SALT LAKE CITY, May 12, 2020 (GLOBE NEWSWIRE) -- The board of directors (the Board) of Health Catalyst, Inc. ("Health Catalyst, Nasdaq: HCAT ), a leading provider of data and analytics technology and services to healthcare organizations, named Mark Templeton to its Board and its nominating and corporate governance committee, effective June 15, 2020.
  • Mr. Templeton was appointed to fill an upcoming vacancy after Promod Haques current term expires at Health Catalysts 2020 annual meeting of its stockholders on June 12, 2020.
  • We are honored to add Mark Templeton to our Board to enhance Health Catalysts ability to continue to achieve our mission to be the catalyst for massive, measurable, data-informed healthcare improvement, said Dan Burton, CEO of Health Catalyst.
  • I look forward to lending my perspectives and expertise to support the Board and the Health Catalyst team in the journey to grow and scale.

Catalyst Biosciences Receives Patent in the European Union for Its Factor IX Portfolio

Retrieved on: 
Tuesday, April 28, 2020
Canoes, Dalca, Patent portfolio, Unitary patent, Economic catalyst

"This newly issued EU patent expands the breadth of our Factor IX intellectual property portfolio.

Key Points: 
  • "This newly issued EU patent expands the breadth of our Factor IX intellectual property portfolio.
  • We now have broad patent coverage in all major markets including the United States, the European Union, Japan and China, said Nassim Usman, Ph.D., Catalysts president and chief executive officer.
  • DalcA has successfully completed a Phase 2b clinical trial and CB 2679d-GT is progressing into non-human primate studies.
  • Catalyst is developing DalcA, a next-generation SQ FIX therapy for the treatment of hemophilia B.

Catalyst Biosciences to Present at the Cowen Healthcare Conference

Retrieved on: 
Monday, February 24, 2020
Cowen, Economic catalyst

SOUTH SAN FRANCISCO, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced thatNassim Usman, Ph.D., president and chief executive officer of Catalyst Biosciences, will present a corporate overview at the Cowen Healthcare Conference at 8:40 a.m.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced thatNassim Usman, Ph.D., president and chief executive officer of Catalyst Biosciences, will present a corporate overview at the Cowen Healthcare Conference at 8:40 a.m.
  • An archived webcast of the presentation will be available for 90 days on the Events and Presentations section on the Companys website.
  • Catalyst is a clinical-stage biopharmaceutical company focused on addressing unmet needs in rare diseases and systemic complement mediated disorders.
  • The Company does not assume any obligation to update any forward-looking statements, except as required by law.

2020 Catalyst Award Winners: Deloitte, Medtronic And Unilever Honored For Inspiring Change, Accelerating Progress For Women In The Workplace

Retrieved on: 
Thursday, January 16, 2020
Businesspeople, Companies, Business, Catalyst, Indra Nooyi, Indra, PepsiCo, Catalysis, Economic catalyst, Unilever

NEW YORK, Jan. 16, 2020 /PRNewswire/ -- Deloitte, Medtronic and Unilever will receive the prestigious 2020 Catalyst Award on March 12 for initiatives that have accelerated progress for women in their organizations.

Key Points: 
  • NEW YORK, Jan. 16, 2020 /PRNewswire/ -- Deloitte, Medtronic and Unilever will receive the prestigious 2020 Catalyst Award on March 12 for initiatives that have accelerated progress for women in their organizations.
  • The 2020 Catalyst Awards Conference will feature a conversation between Catalyst President and CEO Lorraine Hariton and former PepsiCo Chairman and CEO Indra Nooyi.
  • Join the 2020 Catalyst Awards conversation by following Catalyst on Facebook.com/CatalystInc , Instagram.com/CatalystInc , and Twitter.com/CatalystInc , using the hashtags #NowIsTheMoment and #CatalystAwards2020.
  • Founded in 1962, Catalyst drives change with pioneering research, practical tools, and proven solutions to accelerate and advance women into leadershipbecause progress for women is progress for everyone.